These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32481431)

  • 1. Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study.
    Takahashi A; Abe K; Fujita M; Hayashi M; Okai K; Ohira H
    Medicine (Baltimore); 2020 May; 99(22):e20399. PubMed ID: 32481431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.
    Wu G; Li H; Fang Q; Zhang J; Zhang M; Zhang L; Wu L; Hou X; Lu J; Bao Y; Jia W
    Sci Rep; 2017 Jul; 7(1):5095. PubMed ID: 28698650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.
    Takahashi A; Imaizumi H; Hayashi M; Okai K; Abe K; Usami K; Tanji N; Ohira H
    Sports Med Int Open; 2017 Jan; 1(1):E2-E7. PubMed ID: 30539079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease.
    Takahashi A; Abe K; Usami K; Imaizumi H; Hayashi M; Okai K; Kanno Y; Tanji N; Watanabe H; Ohira H
    Int J Sports Med; 2015 Oct; 36(10):848-52. PubMed ID: 26090879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G
    J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
    Liang J; Han T; Gao YT; Jing L; Ma Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease.
    Fealy CE; Haus JM; Solomon TP; Pagadala M; Flask CA; McCullough AJ; Kirwan JP
    J Appl Physiol (1985); 2012 Jul; 113(1):1-6. PubMed ID: 22582214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum Ck18-M65 and M30 levels in patients with chronic hepatitis B combined with nonalcoholic steatohepatitis and liver fibrosis.
    Dai L; Yan Y; Chen Q
    Medicine (Baltimore); 2024 Jun; 103(23):e38342. PubMed ID: 38847670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.
    Alisi A; Ceccarelli S; Panera N; Prono F; Petrini S; De Stefanis C; Pezzullo M; Tozzi A; Villani A; Bedogni G; Nobili V
    PLoS One; 2013; 8(6):e67160. PubMed ID: 23840612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Mandelia C; Collyer E; Mansoor S; Lopez R; Lappe S; Nobili V; Alkhouri N
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):181-7. PubMed ID: 26835904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers.
    Shen J; Chan HL; Wong GL; Choi PC; Chan AW; Chan HY; Chim AM; Yeung DK; Chan FK; Woo J; Yu J; Chu WC; Wong VW
    J Hepatol; 2012 Jun; 56(6):1363-70. PubMed ID: 22314419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance.
    Jiang S; Zhang R; Li H; Fang Q; Jiang F; Hou X; Hu C; Jia W
    J Nutrigenet Nutrigenomics; 2014; 7(3):121-9. PubMed ID: 25359230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
    Tsutsui M; Tanaka N; Kawakubo M; Sheena Y; Horiuchi A; Komatsu M; Nagaya T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Tanaka E; Sano K
    J Clin Gastroenterol; 2010 Jul; 44(6):440-7. PubMed ID: 20104187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 in non-alcoholic fatty liver disease.
    Tucker B; Li H; Long X; Rye KA; Ong KL
    Metabolism; 2019 Dec; 101():153994. PubMed ID: 31672443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
    Qin Y; Zhou Y; Chen SH; Zhao XL; Ran L; Zeng XL; Wu Y; Chen JL; Kang C; Shu FR; Zhang QY; Mi MT
    PLoS One; 2015; 10(7):e0133496. PubMed ID: 26226139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
    Zheng KI; Liu WY; Pan XY; Ma HL; Zhu PW; Wu XX; Targher G; Byrne C; Wang XD; Chen YP; Lu F; Zheng MH
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease.
    Pagano S; Bakker SJL; Juillard C; Dullaart RPF; Vuilleumier N
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.
    Maliken BD; Nelson JE; Klintworth HM; Beauchamp M; Yeh MM; Kowdley KV
    Hepatology; 2013 May; 57(5):1806-13. PubMed ID: 23325576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.